Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Agilent Technologies Inc./ 4

Changes in Beneficial Ownership · 4

Agilent Technologies Inc.

ANYSEEQUITYCurrent

Changes in Beneficial Ownership

Filed Sep 9, 2026Accepted Sep 9, 2026, 4:01 PM EDTFiling CIK 1090872Accession 0001090872-26-000065
View company →Permanent SEC source ↗
Share

Structured filing — 4

form4.xml

Open full document ↗

Filing details

Report period
2026-09-04
Issuer
AGILENT TECHNOLOGIES, INC.
Issuer CIK
0001090872
Trading symbol
A

Reporting owner 1

Name
Dolsten Mikael
Reporting owner CIK
0001437590
Relationship
Director
Address
5301 STEVENS CREEK BLVD., SANTA CLARA, CA, 95051

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-09-04S · Form 4634D151.3754,923.68[F1]D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Footnotes

F1
Includes 9.295 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11. The reporting person has elected to defer these shares of common stock.↩ 1

Signature 1

Signed
/s/ Shirley Qin, attorney-in-fact for Mr. Dolsten
Date
2026-09-09

Company context

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments,

Current securities

ANYSE · EQUITY · Current

Recent company filings

  1. EFFECT filingSep 23, 2026
  2. 424B3 filingSep 23, 2026
  3. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 8, 2026
  4. 144 filingSep 4, 2026
  5. S-4 filingSep 1, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.